Industry News higher dosing accuracy - than any other method currently known .
This information will be paired with blood glucose data via an app to create the first open loop system for insulin pen users . “ When insulin and continuous blood glucose data are combined on a smartphone , the resulting possibilities of providing individually personalised dosing and behaviour recommendations - at the right time – is game-changing ,” says Patients Pending CEO and co-founder , John Sjölund , himself living with Type 1 diabetes for more than 30 years and using such tools . “ Recent developments within automated insulin delivery systems are hugely exciting , but these advances only affect people using insulin pumps to manage their diabetes and I worry that for the foreseeable future these systems may be out of reach for the overwhelming majority of people globally that choose - or are forced because of cost - to use insulin pens ,” Sjölund continues .
The Patients Pending technology will work with all known existing or future insulin pens , uses simple technology and can be produced at a cost low enough to make it viable for even developing markets .
The firm believes this new device , which will be able to measure the amount of insulin injected with exceptional precision , will be the first manufacturer agnostic device that is able to go beyond simple logging , to providing dosage recommendations as part of an intelligent insulin delivery system .
“ For the last five years , we have evaluated dozens of technologies to try to understand how we could create a product that is accurate , simple , and low-cost enough to allow diabetes automation for everyone living with this condition – regardless of financial circumstances . Our new
Timesulin device allows people to keep using the same insulin pen and medicine that they know and trust - whether it comes from companies like Novo Nordisk , Lilly , Sanofi or Biocon - with no prescription or change in routine ,” Sjölund continues . “ Currently , less than 1 % of people with diabetes have access to their own health data and I feel secure in the fact that our device is more accurate than anything else we have encountered .”
Patients Pending believes that providing data to facilitate real-time and automated decision-making will be a ground-breaking step in making life with diabetes simpler , safer and more balanced . The firm plans on submitting a regulatory filing in 2017 . Further , it is currently in discussions with potential commercial partners to determine the best route to bring this product into the hands of as many people with insulin-dependent Type 1 and Type 2 diabetes globally . •
Startupbootcamp Digital Health Berlin Announces Latest Start-up Cohort
Startupbootcamp , Europe ’ s largest accelerator group , has announced the 10 start-ups that will join its Berlin based Digital Health program .
A diverse range of teams covering various business topics – from Behaviour Change programs to women ’ s health and artificial intelligence – were chosen to join the accelerator program which starts on November 7th 2016 .
After reviewing 197 completed applications from 516 in total from 60 countries , the successful start-ups were chosen during an intense , two-day selection process . In total , 21 finalists were invited to attend the Startupbootcamp Digital Health Selection Days in Berlin from 29th to 30th September and pitch their start-ups in intense interviews to 70 program mentors and corporate partners such as arvato CRM Healthcare , Deutsche Apotheker -und Ärtzebank ( apoBank ) , Munich Health , Philips and Sanofi in Germany . The mentors include a wide range of industry experts , healthcare entrepreneurs and investors .
Here are the ten winning teams selected for the 2016 cohort :
FetView , Czech Republic Evidence based decisions for physicians in female and foetal healthcare . The system supports physician ’ s analyses of medical images with Big Data and machine learning .
YuScale , Germany Determines the carbohydrates and other nutritional values of ready to eat meals which is the daily pain point for diabetics .
iRewardHealth , USA An evidence-based incentive program motivating healthy behaviour change through an adaptive reward system adjusting to user ' s level of engagement .
Memoria , Israel A location-based platform aimed at guiding , assisting and monitoring Alzheimer ' s patients throughout their daily routines .
MediLad , Germany A virtual health assistant ( AI ) that provides curated content in women ’ s health and Sexual Transmitted Diseases ( STIs ) through instant messaging platforms .
Paralign , USA A thought and mood tracker with combined AIs that help users identify recurring thought patterns , creating support communities , building an on-demand marketplace for mental health .
Continued on page 14
The Journal of mHealth
13